Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Semih Alpsoy"'
Autor:
Mehdi Ghasemi, Semih Alpsoy, Seyhan Türk, Ümit Y. Malkan, Şükrü Atakan, İbrahim C. Haznedaroğlu, Gürsel Güneş, Mehmet Gündüz, Burak Yılmaz, Sezgin Etgül, Seda Aydın, Tuncay Aslan, Nilgün Sayınalp, Salih Aksu, Haluk Demiroğlu, Osman İ. Özcebe, Yahya Büyükaşık, Hakan Göker
Publikováno v:
Turkish Journal of Hematology, Vol 33, Iss 4, Pp 286-292 (2016)
Objective: Multiple myeloma (MM) is currently incurable due to refractory disease relapse even under novel anti-myeloma treatment. In silico studies are effective for key decision making during clinicopathological battles against the chronic course o
Externí odkaz:
https://doaj.org/article/f4f9f90b278148459d1e22d2fc9074ff
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-10 (2019)
Scientific Reports, 9:8949. Nature Publishing Group
Scientific Reports
Scientific Reports, 9:8949. Nature Publishing Group
Scientific Reports
Chemotherapy is a routine treatment approach for early-stage cancers, but the effectiveness of such treatments is often limited by drug resistance, toxicity, and tumor heterogeneity. Combination chemotherapy, in which two or more drugs are applied si
Autor:
Seda Aydin, Umit Yavuz Malkan, Gursel Gunes, Şükrü Atakan, Burak Yilmaz, Nilgun Sayinalp, Mehdi Ghasemi, Salih Aksu, Osman Özcebe, Seyhan Turk, Sezgin Etgül, Yahya Buyukasik, Tuncay Aslan, Semih Alpsoy, Hakan Goker, Haluk Demiroglu, Mehmet Gunduz, Ibrahim C. Haznedaroglu
Publikováno v:
Turkish Journal of Hematology, Vol 33, Iss 4, Pp 286-292 (2016)
Turkish Journal of Hematology
Turkish Journal of Hematology
Objective: Multiple myeloma (MM) is currently incurable due to refractory disease relapse even under novel anti-myeloma treatment. In silico studies are effective for key decision making during clinicopathological battles against the chronic course o